EDIT vs EXPD
Editas Medicine Inc (EDIT) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
EDIT currently screens at market cap $375.2M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the EDIT and EXPD stock pages for the full models.
Not investment advice.